Healthcare Infection Control Practices Advisory Committee, 48029 [2022-16805]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 150 / Friday, August 5, 2022 / Notices
Dates: October 4–5, 2022.
Times: 11:00 a.m.–5:00 p.m., EDT.
Place: Teleconference.
Agenda: The meeting will convene to
address matters related to the conduct of
Study Section business and for the
Study Section to consider safety and
occupational health-related grant
applications.
FOR FURTHER INFORMATION CONTACT:
Michael Goldcamp, Ph.D., Scientific
Review Officer, NIOSH, 1095
Willowdale Road, Morgantown, West
Virginia 26506; Telephone: (304) 285–
5951; Email: MGoldcamp@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–16806 Filed 8–4–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee
AGENCY:
Public Participation
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Healthcare Infection Control
Practices Advisory Committee
(HICPAC). This virtual meeting is open
to the public, limited only by the
number of audio and web conference
lines (300 audio and web conference
lines are available). Time will be
available for public comment.
Registration is required.
DATES: The meeting will be held on
August 23, 2022, from 12:00 p.m. to 2:00
p.m., EDT.
ADDRESSES: To register for this web
conference, please go to: www.cdc.gov/
hicpac. All registered participants will
receive the meeting link and
instructions shortly before the meeting.
Oral Public Comment: Time will be
available for public comment. Members
of the public who wish to provide
public comments should plan to attend
the public comment session at the start
time listed. Please note that the public
comment period may end before the
time indicated, following the last call
for comments.
Written Public Comment: The public
may submit written comments in
advance of the meeting. Comments
should be submitted in writing by email
to the contact person listed above. The
deadline for receipt of written public
comment is August 15, 2022. All
requests must contain the submitter’s
name, address, and organizational
affiliation, as well as the topic being
addressed. Written comments should
not exceed one single-spaced typed page
in length. Written comments received in
advance of the meeting will be included
in the official record of the meeting.
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Please click the link below to join the
webinar: https://cdc.zoomgov.com/j/
1601692544?pwd=c0tVaHJoVUZSdHJx
TGppWVFiUHNidz09.
Meeting ID: 160 169 2544
Passcode: 07051018
FOR FURTHER INFORMATION CONTACT:
Sydnee Byrd, M.P.A., Program Analyst,
HICPAC, Division of Healthcare Quality
Promotion (DHQP), National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), CDC, 1600 Clifton
Road NE, Mailstop H16–3, Atlanta,
Georgia 30329–4027; Telephone: (404)
718–8039; Email: HICPAC@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged
with providing advice and guidance to
the Director, DHQP; the Director,
NCEZID; the Director, CDC; and the
Secretary, Department of Health and
Human Services, regarding (1) the
practice of healthcare infection
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and (3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters To Be Considered: The agenda
will include the following updates: The
Healthcare Personnel Guideline
Workgroup; Isolation Precautions
Guideline Workgroup; Neonatal
Intensive Care Unit Guideline
Workgroup; and Neonatal Pediatric
Surveillance Workgroup. Agenda items
are subject to change as priorities
dictate.
VerDate Sep<11>2014
17:20 Aug 04, 2022
Jkt 256001
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
48029
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–16805 Filed 8–4–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Safety and
Occupational Health Study Section
ACTION:
Notice.
The Centers for Disease
Control and Prevention (CDC) is seeking
nominations for membership on the
Safety and Occupational Health Study
Section (SOHSS). The SOHSS consists
of 20 experts in fields associated with
occupational medicine and nursing,
industrial hygiene, occupational safety
and engineering, toxicology, chemistry,
safety and health education,
ergonomics, epidemiology, economic
science, psychology, pulmonary
pathology/physiology, and social
science.
DATES: Nominations for membership on
the SOHSS must be received no later
than September 1, 2022. Packages
received after this time will not be
considered for the current membership
cycle.
ADDRESSES: All nominations should be
mailed to Dr. Michael Goldcamp,
National Institute for Occupational
Safety and Health, CDC, 1095
Willowdale Road, Morgantown, West
Virginia 26506, or emailed
(recommended) to MGoldcamp@
cdc.gov.
FOR FURTHER INFORMATION CONTACT:
Michael Goldcamp, Ph.D., Scientific
Review Officer, National Institute for
Occupational Safety and Health, CDC,
1095 Willowdale Road, Morgantown,
West Virginia 26506; Telephone: (304)
285–5951; Email: MGoldcamp@cdc.gov.
SUPPLEMENTARY INFORMATION:
Nominations are being sought for
SUMMARY:
E:\FR\FM\05AUN1.SGM
05AUN1
]]>Agencies
[Federal Register Volume 87, Number 150 (Friday, August 5, 2022)]
[Notices]
[Page 48029]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-16805]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Healthcare Infection Control
Practices Advisory Committee (HICPAC). This virtual meeting is open to
the public, limited only by the number of audio and web conference
lines (300 audio and web conference lines are available). Time will be
available for public comment. Registration is required.
DATES: The meeting will be held on August 23, 2022, from 12:00 p.m. to
2:00 p.m., EDT.
ADDRESSES: To register for this web conference, please go to:
www.cdc.gov/hicpac. All registered participants will receive the
meeting link and instructions shortly before the meeting. Please click
the link below to join the webinar: https://cdc.zoomgov.com/j/1601692544?pwd=c0tVaHJoVUZSdHJxTGppWVFiUHNidz09.
Meeting ID: 160 169 2544
Passcode: 07051018
FOR FURTHER INFORMATION CONTACT: Sydnee Byrd, M.P.A., Program Analyst,
HICPAC, Division of Healthcare Quality Promotion (DHQP), National
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), CDC,
1600 Clifton Road NE, Mailstop H16-3, Atlanta, Georgia 30329-4027;
Telephone: (404) 718-8039; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged with providing advice and
guidance to the Director, DHQP; the Director, NCEZID; the Director,
CDC; and the Secretary, Department of Health and Human Services,
regarding (1) the practice of healthcare infection prevention and
control; (2) strategies for surveillance, prevention, and control of
infections, antimicrobial resistance, and related events in settings
where healthcare is provided; and (3) periodic updating of CDC
guidelines and other policy statements regarding prevention of
healthcare-associated infections and healthcare-related conditions.
Matters To Be Considered: The agenda will include the following
updates: The Healthcare Personnel Guideline Workgroup; Isolation
Precautions Guideline Workgroup; Neonatal Intensive Care Unit Guideline
Workgroup; and Neonatal Pediatric Surveillance Workgroup. Agenda items
are subject to change as priorities dictate.
Public Participation
Oral Public Comment: Time will be available for public comment.
Members of the public who wish to provide public comments should plan
to attend the public comment session at the start time listed. Please
note that the public comment period may end before the time indicated,
following the last call for comments.
Written Public Comment: The public may submit written comments in
advance of the meeting. Comments should be submitted in writing by
email to the contact person listed above. The deadline for receipt of
written public comment is August 15, 2022. All requests must contain
the submitter's name, address, and organizational affiliation, as well
as the topic being addressed. Written comments should not exceed one
single-spaced typed page in length. Written comments received in
advance of the meeting will be included in the official record of the
meeting.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-16805 Filed 8-4-22; 8:45 am]
BILLING CODE 4163-18-P
